Finance

Lists
SMTI:NASDAQ
Sanara Medtech Inc
USD 32,80
-0,24%
(-0,080) 1D
USD 32,80
0,00% (0,00)
After hours
Closed: 23 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMTI...
Open
USD 32,69
High
USD 32,99
Low
USD 32,44
Mkt. cap
301,37 m
Avg. vol.
177,69 k
Volume
60,13 k
52-wk high
USD 35,52
52-wk low
USD 16,05
EPS
-USD 3,70
Beta
1,19
Shares outstanding
9,19 m
No. of employees
108
Open
USD 32,69
High
USD 32,99
Low
USD 32,44
Mkt. cap
301,37 m
Avg. vol.
177,69 k
Volume
60,13 k
52-wk high
USD 35,52
52-wk low
USD 16,05
EPS
-USD 3,70
Beta
1,19
Shares outstanding
9,19 m
No. of employees
108
News stories
From web sources and news partners
About Sanara Medtech Inc
CEO-
Employees108
Founded2001
HeadquartersFort Worth, Texas, Verenigde State van Amerika
SectorMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to SMTI in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SMTI in the last 3 months.
Highest
Current USD 32,80
USD 35,00 (+6,71%)
Average
USD 35,00 (+6,71%)
Lowest
USD 35,00 (+6,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Frank Takkinen
Lake Street
Hold
Reiterated
USD 35,00
+6,7%
08/26/2026
Ilya Zubkov
Freedom Capital Markets
Hold
Downgraded
USD 35,00
+6,7%
08/03/2026
Yi Chen
H.C. Wainwright
Hold
Downgraded
USD 35,00
+6,7%
07/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
26,33 m
27,55 m
27,80 m
28,14 m
Cost of goods sold
1,87 m
1,87 m
1,92 m
1,98 m
Cost of revenue
1,87 m
1,87 m
1,92 m
1,98 m
Research and development expenses
1,03 m
2,04 m
759,59 k
1,15 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,88 m
20,08 m
21,88 m
22,60 m
Operating expense
21,52 m
22,78 m
23,23 m
24,38 m
Total operating expenses
23,39 m
24,65 m
25,15 m
26,36 m
Operating income
2,94 m
2,89 m
2,65 m
1,78 m
Other non operating income
-
-
-
-
EBT including unusual items
834,49 k
-1,11 m
397,69 k
-411,14 k
EBT excluding unusual items
834,49 k
733,81 k
397,69 k
-409,77 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-30,41 m
-1,61 m
458,96 k
-452,86 k
Net profit margin
-115,48%
-5,84%
1,65%
-1,61%
Earnings per share
-
-
0,04
0,09
Interest and investment income
-
-
12,96 k
53,81 k
Interest expense
-1,82 m
-1,83 m
-1,80 m
-1,81 m
Net interest expenses
-1,82 m
-1,83 m
-1,79 m
-1,76 m
Depreciation and amortization charges
610,90 k
668,40 k
587,25 k
619,11 k
EBITDA
3,61 m
3,56 m
3,23 m
2,40 m
Gain or loss from assets sale
-
-
-
1,38 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme